| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/16/2004 | US20040254238 Bone growth stimulation with NO/statin and other NO modulating combinations |
| 12/16/2004 | US20040254235 homoserine lactone derivatives that stimulate or promote the metabolism, growth and/or recovery of microorganisms |
| 12/16/2004 | US20040254234 Medicament for prevention and/or therapy of arterial wall disorder |
| 12/16/2004 | US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 12/16/2004 | US20040254232 Use of cationic surfactant as activity enhancer in deodorants and oral care |
| 12/16/2004 | US20040254231 Antiinflammatory agents; alcoholism; antiallergens; chronic obstructive pulmonary disease; cardiovascular disorders; antiarthritic agents; autoimmune disease; chronic fatigue syndrome; multiple sclerosis |
| 12/16/2004 | US20040254230 Method for treating ocular hypertension |
| 12/16/2004 | US20040254229 Use of glucose uptake enhancer for reducing apoptosis |
| 12/16/2004 | US20040254228 Treatment of chronic heart failure |
| 12/16/2004 | US20040254227 prevent reproduction of herpes c virus; viricides; antiproliferative agents; prevention infections |
| 12/16/2004 | US20040254225 Modulation of opioid receptor by binding |
| 12/16/2004 | US20040254223 Process for the preparation of amorphous form of torsemide |
| 12/16/2004 | US20040254222 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 12/16/2004 | US20040254220 Histone deacetylase inhibitors |
| 12/16/2004 | US20040254219 Muscarinic receptors; chronic obstructive pulmonary disease; asthma |
| 12/16/2004 | US20040254216 Inhibitors of p38 |
| 12/16/2004 | US20040254215 Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 12/16/2004 | US20040254214 7-Amido-isoindolyl compounds and their pharmaceutical uses |
| 12/16/2004 | US20040254213 Use of bicyclo compounds for treating alzheimer's disease |
| 12/16/2004 | US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/16/2004 | US20040254211 Alpha v integrin receptor antagonists |
| 12/16/2004 | US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/16/2004 | US20040254208 Compositions for affecting weight loss |
| 12/16/2004 | US20040254207 linked via an alkylene bridge to the nitrogen atom of a 1,2-benzisothiazol-3(2H)-one 1,1-dioxide group; also containing an opioid analgesic; enhanced analgesic potency and are free from antipyretic activity, do not suppress blood coagulation, and have little hepatotoxic effect. |
| 12/16/2004 | US20040254203 Methods and compositions utilizing quinazolinones |
| 12/16/2004 | US20040254202 Method of promoting sleep using topical administration of vasoactive agents |
| 12/16/2004 | US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants |
| 12/16/2004 | US20040254199 For plants, animals; nematocides |
| 12/16/2004 | US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 12/16/2004 | US20040254194 Treatment of bacterial diseases of the respiratory organs |
| 12/16/2004 | US20040254193 Novel tetrahydroquinolines |
| 12/16/2004 | US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 12/16/2004 | US20040254191 Antiinflammatory agents; autoimmune diseases; controlling tumor necrosis factor; immunosuppressants |
| 12/16/2004 | US20040254190 3-Benzhydrylidene-8-aza-bicyclo[3.2.1]octane derivatives with opioid receptor activity |
| 12/16/2004 | US20040254189 Jnk inhibitors |
| 12/16/2004 | US20040254187 5-ethyl-imidazotriazinones |
| 12/16/2004 | US20040254186 Pyridylfurans and pyrroles as raf kinase inhibitors |
| 12/16/2004 | US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects |
| 12/16/2004 | US20040254184 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders |
| 12/16/2004 | US20040254183 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections |
| 12/16/2004 | US20040254182 Enhanced propertied pharmaceuticals |
| 12/16/2004 | US20040254181 Process for the preparation of 9-deazaguanine derivatives |
| 12/16/2004 | US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 12/16/2004 | US20040254176 Hypotensive agents; cardiovascular disorders; antidiabetic agents; skin disorders;kidney disorders; headaches; vision defects; strokes; synergistic mixture of amlodipine, benazepril and hydrochlorothiazide; oral administering |
| 12/16/2004 | US20040254175 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 12/16/2004 | US20040254174 Chromatography; separation of enantiomorphs |
| 12/16/2004 | US20040254173 Modulation of dopamine responses with substituted (S)-2,3-benzodiazepines |
| 12/16/2004 | US20040254172 Method of treating nausea, vomiting, retching or any combination thereof |
| 12/16/2004 | US20040254171 Method of treating nausea, vomiting, retching or any combination thereof |
| 12/16/2004 | US20040254170 Administering serotonine receptor antagonist; irritable bowel disorders |
| 12/16/2004 | US20040254169 Method of treating functional bowel disorders |
| 12/16/2004 | US20040254168 Irritable bowel disorders; serotonine receptor antagonist |
| 12/16/2004 | US20040254167 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/16/2004 | US20040254166 Substituted phenyl acetamides and their use as protease inhibitors |
| 12/16/2004 | US20040254165 Vitiligo; skin cancer; control skin coloring |
| 12/16/2004 | US20040254161 New benzothiazine and benzothiadiazine compounds |
| 12/16/2004 | US20040254160 Benzothiazepine derivatives |
| 12/16/2004 | US20040254156 opioid receptor agonists such as 2-[4-(methanesulfonylamino-methyl)-phenyl]-N-methyl-N-[1-(S)-phenyl-2-pyrrolidin-1-ylethyl]-acetamide used for preventing pain, pruritus and gastrointestinal disorders |
| 12/16/2004 | US20040254155 Porphyrins and metalloporphyrins for inhibiting heme iron uptake |
| 12/16/2004 | US20040254154 Prediction of changes to visual acuity from assessment of macular edema |
| 12/16/2004 | US20040254153 Potentiation adenosine 3',5'-cyclic monophosphate in urogenital system of female |
| 12/16/2004 | US20040254152 Cognition activators; therapy for brain inflammation; activation of monocytes; reduce brain inflamamtion; Alzheimer's disease; Parkinson's disease; multiple sclerosis; antidepressants; bipolar disorders; Cushing disorders |
| 12/16/2004 | US20040254151 Osteoporosis, bone cancer; antiarthritic agents;paget's disease; antiinflammatory agents |
| 12/16/2004 | US20040254149 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy |
| 12/16/2004 | US20040254148 Pharmaceutical composition effective in treatment of mechanical allodynia, screening method of potential compound as said pharmaceutical composition, inspection method of mechanical allodynia, and treatment method of mechanical allodynia |
| 12/16/2004 | US20040254147 Using hexafluorophosphate salt of pyridinium, imidazolium compound |
| 12/16/2004 | US20040254146 Carboxylate salts of galantamine and their pharmaceutical use |
| 12/16/2004 | US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 12/16/2004 | US20040254144 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma |
| 12/16/2004 | US20040254143 Compositions and methods for the treatment or prevention of inflammation |
| 12/16/2004 | US20040254142 Arthritic and joint condition formulation |
| 12/16/2004 | US20040254141 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents |
| 12/16/2004 | US20040254137 Nucleotide sequences; for therapy of bone disorders, chondrondysplasis; biodrug; activation caspase signaling cascade |
| 12/16/2004 | US20040254129 In aqueous solution;prevent cell damage; mixture with drug or nitritional supplment |
| 12/16/2004 | US20040254128 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 12/16/2004 | US20040254126 11-12 Bicyclic erythromycin derivatives |
| 12/16/2004 | US20040254125 Anthelmintic composition |
| 12/16/2004 | US20040254124 Macrolides |
| 12/16/2004 | US20040254123 Using benzylidene ascorbate in mixture with carrier |
| 12/16/2004 | US20040254122 increasing the tryptophan:large neutral amino acids ratio in blood by orally administering a rapidly digestible blend of no more than 40 g carbohydrate and a high tryptophan containing protein |
| 12/16/2004 | US20040254121 Intrauterine growth restriction - and a postulated treatment modality for clinical research and it's biochemical rationale |
| 12/16/2004 | US20040254118 Reducing axon degeneration with proteasome inhibitors |
| 12/16/2004 | US20040254117 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 12/16/2004 | US20040254114 Genetic engineering |
| 12/16/2004 | US20040254110 Methods for diagnosing and treating Alzheimer's disease |
| 12/16/2004 | US20040254100 Use of thiostrepton as an anti-mycobacterial agent |
| 12/16/2004 | US20040254098 Therapy, diagnosis, or electronic component |
| 12/16/2004 | US20040254096 Mucin synthesis inhibitors |
| 12/16/2004 | US20040254095 Supplement for treating musculoskeletal disorders |
| 12/16/2004 | US20040254094 Antiproliferative agents for Dna virus |
| 12/16/2004 | US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents |
| 12/16/2004 | US20040254092 Using mixture of ozone and perfluorohydrocarbon; liquid sterilization therapy |
| 12/16/2004 | US20040253730 Identifying modulators which induce apoptosis and activate cell cycle checkpoint systems; for use in treatment and prevention of cell proliferative disorders |
| 12/16/2004 | US20040253725 Control of arthropod vectors of parasitic diseases |
| 12/16/2004 | US20040253723 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 12/16/2004 | US20040253697 Nucleotide sequences coding epothilone polyketide synthase for use in generating fungicides, immunosuppressants and/or antitumor agents in microorganisms; bioreactors and heterologous gene expression |
| 12/16/2004 | US20040253690 Process for producing isomaltose and use thereof |
| 12/16/2004 | US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders |
| 12/16/2004 | US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders |
| 12/16/2004 | US20040253651 Detected from secreted glycoprotein (such as matrix metalloproteinases, prostate specific antigen, kallikrein 2, human chorionic gonadotrophin or carcinoembryonic antigen); glycosyltransferases; for diagnosing and targeting cell proliferative disorders; vaccines |